We're working on profiling this company soon. Let us know you're interested by sending us a request here »
We're working hard to bring you this company's profile. Register here to get an alert as soon we're done.
In the meantime, if you are interested in participating in placements on this stock click "Follow" on the toolbar above.
ASX tips up just 0.1pc with eight sectors lower Energy, resources lead gains, outweighing losses Dr...
Read ArticleASX rises 0.4pc with eight of 11 sectors higher Materials, major banks lead gains Myer takes an abs...
Read ArticleASX 200 closes in red ahead of US Federal Reserve interest rate decision Energy sector jumps as Ukr...
Read ArticleThe S&P ASX 200 Health Care index fell 13.21% in August as a tough reporting season weighed on...
Read ArticleASX down 0.30pc on across-market weakness Big cap stocks trade ex-dividend, applying downward press...
Read ArticleThe life sciences stocks that boomed during the pandemic have applied their experience to fresh app...
Read ArticleASX ends flat after setting new intraday high Gold, small caps prop up market in face of bank losse...
Read ArticleMorning, and welcome to Stockhead’s Top 10 (at 11… ish), highlighting the movers and shakers on the...
Read ArticleASX closes out week-long rally on new record high of 8938 points Market set a new intraday high eve...
Read ArticleMorning, and welcome to Stockhead’s Top 10 (at 11… ish), highlighting the movers and shakers on the...
Read ArticleCommonwealth Bank shares fall 5pc on yearly results ASX falls from near all-time highs as sell down...
Read ArticleThe S&P ASX 200 Health Care index rose 9.05% in July with rotation into the sector gaining mome...
Read ArticleASX ends flat, overcoming difficult trading session Gold stocks lead gains with index up 3.57pc Inf...
Read ArticleMorning, and welcome to Stockhead’s Top 10 (at 11… ish), highlighting the movers and shakers on the...
Read ArticleCopper prices crash 20pc Materials sector undercuts market, down 2.57pc Info tech rally not enough...
Read ArticleASX falls 0.31pc with 10 of 11 sectors down Healthcare moves against the grain, up 1.04pc Fortescue...
Read ArticleResource stocks fuel market gains again, up 0.96pc 10 of 11 sectors higher as trade deal provides m...
Read ArticleIron ore surges to four-month highs at US$104/tonne Gold lifts 1.4pc to five-week high Banks mostly...
Read ArticleASX shrugs off tariff pessimism to climb 0.59pc Gains led by gold and banking stocks Major banks jo...
Read ArticleMorning, and welcome to Stockhead’s Top 10 (at 11… ish), highlighting the movers and shakers on the...
Read ArticleThe ASX 200 Health Care Index fell 1.05% in June and remains the worst performing sector YTD down 6...
Read ArticleMorning, and welcome to Stockhead’s Top 10 (at 11… ish), highlighting the movers and shakers on the...
Read ArticleMorning, and welcome to Stockhead’s Top 10 (at 11… ish), highlighting the movers and shakers on the...
Read ArticleASX sets new record close at 8587.2 points, breaking February 2025 heights 10 of 11 sectors on the...
Read ArticleDespite a strong start, the ASX has paired back gains to finish down 2.9 points or 0.03pc Weakness...
Read ArticleThe S&P/ASX 200 Health Care Index rose 1.59% in May but remains worst performing sector YTD dow...
Read ArticleASX adds 52 points, hitting a new 50-day high at 8,466.70 points Broad strength with 9 of 11 sector...
Read ArticleHighlights ASX 200 opens with broad sector strength led by resources and tech Eclipse Met...
Read ArticleASX climbs 0.3pc Gold stocks surge, up almost 2pc Retail sales soften, increasing chance of RBA rat...
Read ArticleMorning, and welcome to Stockhead’s Top 10 (at 11… ish), highlighting the movers and shakers on the...
Read ArticleASX slides 0.45pc, falling from new 50-day high Gold and resources stocks temper losses Info Tech s...
Read ArticleASX gains 0.62pc in trading today RBA cut rates as expected, lopping 25 basis points off the cash r...
Read ArticleHighlights Amplia Therapeutics (ASX:ATX) surges following positive pancreatic cancer trial upd...
Read ArticleMorning, and welcome to Stockhead’s Top 10 (at 11… ish), highlighting the movers and shakers on the...
Read ArticleHighlights: ASX tracking upward, following strong global market trends driven by US-UK trade d...
Read ArticleMorning, and welcome to Stockhead’s Top 10 (at 11… ish), highlighting the movers and shakers on the...
Read ArticleMorning, and welcome to Stockhead’s Top 10 (at 11… ish), highlighting the movers and shakers on the...
Read ArticleHighlights: XPON Technologies completes acquisition of Alpha Digital, supporting AI service ex...
Read ArticleMorning, and welcome to Stockhead’s Top 10 (at 11… ish), highlighting the movers and shakers on the...
Read ArticleThe S&P/ASX 200 Health Care Index rose 2.16% in April with the S&P/ASX 200 rallying 3.6% Mo...
Read ArticleMorning, and welcome to Stockhead’s Top 10 (at 11… ish), highlighting the movers and shakers on the...
Read ArticleASX falls 0.82pc, led down by energy and healthcare stocks Gold rises to all-time high at US$3,215...
Read ArticleCompanies including Cochlear and Telix affirm that tariffs are likely to be a ‘Y2K’ non-event Bell...
Read ArticleASX tanks 4pc, worst drop since may 2020 Gold, copper, Bitcoin hammered in global rout Abacus Stora...
Read ArticleASX takes a hit on tariff fears Gold hits new records again RBA rates decision in focus The ASX...
Read ArticleIn the arvo session, the ASX held on to early gains… by a thread Nervy investor/trader eyes now awa...
Read ArticleASX dips after US futures drop and Israel strikes Gold hits new high, coal stock New Hope soars BYD...
Read ArticleASX dips as traders weigh China’s stimulus against Trump’s tariffs Miners soften blow but insurance...
Read ArticleThe S&P/ASX 200 Health Care Index fell 7.66% in February with the S&P/ASX 200 down 3.79% Mo...
Read ArticleHighlights Biotron (ASX:BIT) faces regulatory scrutiny over disclosure practices. Compliance an...
Read ArticleBiotron (ASX:BIT) has been forced to explain its position to ASX Compliance after being queried by t...
Read ArticleAustralia’s S&P/ASX 200 fell 3.79% in February as global geopolitical and economic uncertaintie...
Read ArticleHighlight Respiri rebrands to Vitasora after raising $4 million to boost growth in the US market...
Read ArticleASX drops on tariff fears; BHP, Rio hit Star Entertainment Group sinks amid financial crisis Life36...
Read ArticleTelix expects three more US product approvals this year Patrys switches to plan B Biotron’s do-or-d...
Read ArticleASX hovers near one-month low, dragged by GYG and banks Domain soars on takeover bid RBA’s bullock...
Read ArticleASX rides the wave ahead of US jobs report Coal stocks tank, but Domino’s soars Traders eye US jobs...
Read ArticleThe S&P/ASX 200 Health Care Index fell 1.85% in December but rose 7.51% overall in 2024 Mesobl...
Read ArticleASX 200 lifts on tech rally, miners struggle Barrick Gold threatens Mali shutdown over shipping res...
Read ArticleThe S&P/ASX 200 Health Care Index rose 2.89% in November as momentum returned to the sector Hea...
Read ArticleASX rises on rally across the board Israel and Hezbollah agree to 60-day ceasefire City Chic tumble...
Read ArticleASX healthcare stocks underperform but optimism grows Uscom, Respiri and Hitiq report mixed results...
Read ArticleHealthcare stocks are doing relatively well globally in 2024 The sector could see more recovery as...
Read ArticleASX closes flat amid shift from banks to miners CPI slows to 2.7pc, first dip within RBA’s target...
Read ArticleBiotron (ASX:BIT) has angered shareholders on HotCopper as the results of its latest COVID-treating...
Read ArticleGood morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highligh...
Read ArticleASX health stocks down in August and trail the broader market in 2024 CSL up 6,000pc since listing;...
Read ArticleS&P/ASX 200 Health Care index up 5pc in July, 9.5pc YTD Health sector gains momentum with expec...
Read ArticleThe EMA has rejected the Alzheimer’s drug Leqembi, developed by Eisai and Biogen There is one ASX-l...
Read ArticleASX 200 punches it, record highs back in view 11 of 11 sectors higher, like a well-oiled machine...
Read ArticleThe ASX Health Care index saw a 4% increase in June Growth was driven by CSL and Cochlear Best biot...
Read ArticleBiotron (ASX:BIT) has announced that preliminary data analyses from the BIT225-011 Phase 2 c...
Read ArticleASX closes lower, but Energy sector blinks green Uranium mining stocks surged on Peter Dutton’s nuc...
Read ArticleBiotron jumps after Phase 2 trial success Biotron (ASX:BIT) jumped +15% this morning after announcin...
Read ArticleShares in otherwise thinly traded healthcare microcap Biotron Limited (ASX:BIT) jumped 14.6% to 5.5c...
Read ArticleBiotron (ASX: BIT) has received further indications that its lead antiviral drug BIT225 is a potenti...
Read ArticleStockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) pe...
Read ArticleS&P/ASX 200 Health Care closed flat in May 2024 brings challenges, but hopes are high for biot...
Read ArticleResearch shows Alzheimer’s is entirely preventable A poor diet and bad gut bacteria can increase th...
Read ArticleASX Health sector was in correction territory in April Why is the health sector different from othe...
Read ArticleThere’s been a breakthrough in acne treatment Scientists have found a way to use skin bacteria to c...
Read ArticleBiotron has announced preliminary analyses of data from the BIT225-010 Phase 2 clinical tria...
Read Article05 Apr 2024 - A snapshot of the stocks on the move, featuring Linius Technologies Ltd (ASX:LNU), Bio...
Read ArticleBiotron (ASX: BIT) has obtained promising early results from a phase 2 clinical trial of the company...
Read ArticleTo register for today's webinar click here. Linius Technologies Ltd (ASX:LNU) has signed a second...
Read ArticleThe market may be falling today, but that hasn't stopped Biotron Ltd (ASX: BIT) shares from rocketin...
Read ArticleThe ASX 200 slipped by -0.3% on Tuesday, tracking movements on Wall Street overnight. The local mar...
Read ArticleASX Health Index down -1.5% for February 76 biotechs rose, and 78 fell during the month But essenti...
Read ArticleViking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on p...
Read ArticleLocal markets end +0.13% higher in quasi-comeback Consumer Staples soar on bumper Coles news, but...
Read ArticleXi and Biden set to agree on restricting fentanyl Fentanyl is a synthetic opioid responsible for t...
Read ArticleStockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might h...
Read ArticleWe’ve all heard that “trend is your friend.” And who doesn’t like riding a trend? Trend or momentum...
Read ArticleThe S&P ASX 200 fell -3.8% in October with mid-caps falling -6.94% and small-caps down -5.45% f...
Read ArticleNews relating to Novo Nordisk’s Ozempic has led to a selloff in some ASX stocks CSL, FPH, and RMD f...
Read ArticleMomentum trading involves taking advantage of, and making profits from, upward trends in a stock. Th...
Read ArticleThe Week That Was The world looks very different this week after the addition of what Barclays econo...
Read ArticleBenchmark index finishes Friday ahead +0.4% Sectors led by Financials Small caps dominated by Di...
Read ArticleBenchmark index falls to 11-month lows Utilities only sector in green Small caps led by Noxopharm...
Read ArticleBenchmark index falls on Monday, closing out the day down 0.21% Utilities and Materials sectors ed...
Read ArticleAussie Futures lower, but shares likely to show reilience RBA cash rate decision to be the main foc...
Read ArticleWe look at which ASX stocks are trading on a momentum 52-week high and RSI are two indicators of mo...
Read ArticleThe Economic Week That Was As I return to the fold on a blistering Sunday arvo in Sydenham, my steel...
Read ArticleThis week’s Bulls N’ Bears profiled ASX runner is … Pioneer Resources. It jumped 95 per cent to join...
Read ArticleBenchmark index, up +0.34%, ends month on a positive after dropping -1.5% in September Materials Se...
Read ArticleStockhead’s Top 10 at shortly-before-11-ish, produced in a tearing rush because it’s the Friday befo...
Read ArticleL’Oréal to take minority stake in Chinese startup Shinehigh Innovation Shinehigh is developing supr...
Read ArticleBenchmark index settles almost -0.6% lower on Tuesday All sectors bar Healthcare and Financials in...
Read ArticleStockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might h...
Read ArticleThe FDA has just approved an emergency use authorisation for new Covid-19 vaccines What is emergenc...
Read ArticleAustralian biotech has attracted US investments in the last five years Among ASX stocks to get fund...
Read ArticleAustralian company Biotron (ASX:BIT) has announced that all participants in the Phase 2 COVI...
Read ArticleBiotech could be a US$4 trillion industry in 10 years Genetic engineering and weight loss are two g...
Read ArticleLumos surges on patent granted in Japan and Europe Singular Health announces strategic investment...
Read ArticleThe end of pandemic and higher rates have subdued biotech market But there are signs now the sector...
Read ArticleSydney-based company Inventia Life Science has announced a new distribution agreement with B...
Read ArticleBiotech is making a comeback in 2023 There’s been a couple of breakthroughs on the ASX this year We...
Read ArticleBiotron (BIT) enters phase II of its COVID-19 clinical trial using its lead antiviral drug, BIT225,...
Read ArticleArtificial intelligence is set to disrupt the healthcare sector AI could also help in drugs discove...
Read ArticleThe FDA declined regulate CBD-based supplements and food, citing safety reasons CBD products have g...
Read ArticleJapanese startup OUI is on a mission to halve the world’s blindness with its smartphone-based devic...
Read ArticleASX 200 edges higher, small cap index falls 0.44% 7 out of 11 sectors were in the green with Tech...
Read ArticleStockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) pe...
Read ArticleASX health stocks have been out of favour this year with rotation away from growth to value sector...
Read ArticleStockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) pe...
Read ArticleWe take a look at how the 15 biotech IPOs that listed in 2021 are faring now Only two IPO stocks fr...
Read ArticleBlood clot programs have taken the spotlight recently as new discoveries made Two ASX health stocks...
Read ArticleBiotron (BIT) completes recruitment of the phase two HIV-1 clinical trial with its lead antiviral dr...
Read ArticleBiotron (ASX:BIT) has announced the commencement of a human clinical trial of its lead antiv...
Read ArticleThe ASX 200 falls 2.6% after Wall St rout Small caps recover manfully to be just 1% lower AQC is...
Read ArticleBiotron commences human trial of COVID-19 Pancreatic trial news from Noxopharm and Clarity Pharma V...
Read ArticleBiotron (BIT) launches a human trial of its lead antiviral drug against COVID-19The trial of Biotron...
Read ArticleStockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) per...
Read ArticleBiotron (ASX:BIT) has announced that a Phase 2 HIV-1 clinical trial of its lead antiviral dr...
Read ArticleThe ASX 200 loses 1.2%, XEC sheds 0.9% Weak leads, sour sentiment hobble Asia-Pac markets BPH adds...
Read ArticleBiotron (BIT) finishes recruiting patients for its phase two HIV-1 clinical trial of its lead antiv...
Read ArticleWhat are the risks of investing in biotechs? How to value a biotech Top 10 crucial trials coming up...
Read ArticleUS FDA approves the first clinical trial using naturally derived psychedelic drugs It could open po...
Read ArticleA recent research reveals which biotech segments VCs are ploughing billions of dollars into We list...
Read ArticleBiotron (BIT) receives positive US FDA guidance for its lead antiviral drug, BIT225, as a potential...
Read ArticleInvion demonstrates high efficacy of INV043 when used as a combined therapy Biotron gets positive f...
Read ArticleThe interest rate rise came and the markets fell, then turned a corner. The question now is — will t...
Read ArticleBiotron (ASX:BIT) has announced its lead clinical drug BIT225 has demonstrated effective pro...
Read ArticleCentral Banks have their fingers on the fun button this week, and the markets are pricing in the big...
Read ArticleThose that believe that COVID-19 is yesterday’s news should look at the Biotron Limited (ASX: BIT)...
Read ArticleBiotech company Biotron (BIT) says a new study of its lead clinical drug, BIT225, has been shown to...
Read ArticleThe Healthcare sector has been struggling as the pandemic wanes But most money managers are still b...
Read ArticleThe healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak mark...
Read ArticleBiotech sector has had a tough time recently But there are signs of things improving this year A lo...
Read ArticleBiotron (ASX:BIT) says its lead clinical asset BIT225 has again demonstrated substantial and...
Read ArticleThe Emerging Companies Index (XEC) climbed more than 2% higher on Thursday, before closing at 1.9%,...
Read ArticleBiotron’s (BIT) lead drug, BIT225, has again demonstrated its effectiveness against SARS-CoV-2 (COV...
Read ArticleTelehealth was already a growing space even before the pandemic, but COVID had launched it into the...
Read ArticleThe ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial t...
Read ArticleAt the time of writing, the ASX XHJ Healthcare index is up 5.55% over the last five trading days, be...
Read ArticleIt’s been a rocky two weeks for small-cap health companies with 42 gaining ground, 76 losing it, and...
Read ArticleThe life sciences sector has emerged into the spotlight ever since the pandemic began. In the US, th...
Read ArticleWhile US markets rose after the Fed outlined plans to gradually withdraw stimulus, our markets did n...
Read ArticleIt’s been a rocky two weeks for small-cap health companies, with 27 companies gaining ground, 89 los...
Read ArticleFor the second month in a row the ASX was hit by a major sell-off in the last few days of the month...
Read ArticleASX recovered some lost ground in arvo trade but still finished 0.54% down, as markets continue to b...
Read ArticleStockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) per...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleWall Street closed for Thanksgiving No major leads from global markets overnight, as Wall Street was...
Read ArticleBIT225 administered orally significantly reduced viral load in the lungs and blood of animals chall...
Read ArticleThe ASX closed just 0.11% higher today but there were no shortage of small cap winners, led by Antiv...
Read ArticleAntiviral biotechnology stock Biotron (ASX:BIT) turned heads on the ASX this morning, after announci...
Read ArticleBiotron’s (BIT) lead drug, BIT225, has been effective against COVID-19 in animals The drug was give...
Read ArticleThe Biotron Limited (ASX: BIT) share price is rocketing upwards today after the company announced i...
Read ArticleBiotron (ASX:BIT) has announced that its lead clinical asset, BIT225, has demonstrated subst...
Read ArticleStockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) per...
Read ArticleIt’s been a rocky two weeks for small-cap health companies, with 33 companies gaining ground, 86 los...
Read ArticleBiotron (ASX:BIT) has commenced two clinical trials with its lead antiviral drug BIT225 in H...
Read ArticleBiotron (ASX:BIT) has commenced two clinical trials with its lead antiviral drug BIT225 in H...
Read ArticleAlthough earnings results were the main theme in August, there were also some notable healthcare bre...
Read ArticleIn the spirit of the recently-concluded Olympics and ongoing Paralympics, congratulations to the bac...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with only 45 companies gaining ground, 7...
Read ArticleThe ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 7...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has ret...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks f...
Read ArticleIt’s easy to just think of Pfizer and AstraZeneca as the only two companies fighting COVID-19 in Aus...
Read ArticleASX large cap biotech Mesoblast (ASX:MSB) is not alone in fighting Acute Respiratory Distress Syndro...
Read ArticleSummary ASX 200 listed retail company Unibail-Rodamco-Westfield disclosed a €9.0 billion RESET pl...
Read ArticleThe hunt for a COVID-19 vaccine is ramping up. We learnt yesterday that the government has spent $1....
Read ArticleIn afternoon trade the S&P/ASX 200 Index (ASX: XJO) is on course to snap its losing streak with...
Read ArticleThe chase for effective COVID-19 treatments is well and truly on after biotech company Biotron (ASX:...
Read ArticlePharmaxis (ASX:PXS) and Biotron (ASX:BIT) have gone in polar opposite directions in 2020 and today t...
Read ArticleThe Biotron Limited (ASX: BIT) share price has rocketed higher on Monday after the release of an up...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleA quick wrap of the ASX’s key winners and losers on Tuesday, July 7. Data is taken after the market...
Read ArticleThe Biotron Limited (ASX: BIT) share price soared by 30% today, after the biotechnology company rel...
Read ArticleA quick wrap of the key winners and losers on Monday, July 6. Data is taken after the market closes...
Read ArticleBiotron’s (ASX: BIT) lead candidate HIV-1 drug BIT225 has been shown to boost the body’s immune resp...
Read ArticleBiotron (ASX:BIT) has announced it will present the latest data on BIT225 HIV-1 at the 23rd...
Read ArticleTypically patients with HIV need to stay on treatment for life but that may no longer be the case if...
Read ArticleThe Biotron Limited (ASX: BIT) share price is soaring higher this morning after the small-cap ASX h...
Read ArticleThe S&P/ASX 200 index (ASX: XJO) has followed the lead of U.S. markets and is tumbling lower on...
Read ArticleJatenergy (ASX:JAT) shares are surging after the company said it booked record sales and revenue in...
Read ArticleClinical stage company Biotron (ASX: BIT) is preparing to present results from its ongoing Phase 2 t...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleThere are dozens of vaccines, antiretrovirals and new supportive therapies being feverishly tested a...
Read ArticleAs with the early medical cannabis plays, a cluster of ASX-listed stocks has wasted little time atta...
Read ArticleThe spread of coronavirus has infected global share markets with the contagion of fear. The S&P...
Read ArticleIn February, mounting coronavirus-led uncertainty finally culminated in a late-month share price blo...
Read ArticleStockhead’s resident Health and Biotech expert Tim Boreham is putting down the microscope and pickin...
Read ArticleAs the coronavirus death toll rises to more than 1,000 and the World Health Organisation labels it a...
Read ArticleWith the market returning to form and charging higher on Tuesday, it will come as no surprise to le...
Read ArticleToday’s session proved much kinder to the Aussie market, delivering strong gains across the board as...
Read ArticleAustralian shares rose to a two-week high as investors weighed positive overnight leads against the...
Read ArticleBiotron (ASX:BIT) has joined the global search for a coronavirus vaccine by confirming it is...
Read ArticleA fresh decade-low for the dollar ended today’s session on a weak note, leaving Australian markets i...
Read ArticleAs the coronavirus death toll overtakes the 2002 SARS outbreak, demand for Holista Colltech’s (HCT)...
Read ArticleThe Biotron Limited (ASX: BIT) share price has been a standout performer on the Australian share ma...
Read ArticleThe S&P/ASX 200 index is on course to end the week deep in the red. In afternoon trade the benc...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleGlobal markets continued their rebound today as commodity prices reversed last week’s losses. Ov...
Read ArticleAustralia’s S&P/ASX 200 (Index: ^AXJO)(ASX: XJO) and ALL ORDINARIES (Index: ^AXAO) (ASX: XAO) i...
Read ArticleThe S&P/ASX 200 index has followed the lead of U.S. markets and is pushing higher again. In aft...
Read ArticleFollowing market speculation in January, Biotron (BIT) has emerged as a potential runner in the rac...
Read ArticleAs global authorities race to contain the outbreak of coronavirus, Aussie healthcare stock Biotron (...
Read ArticleAustralian clinical stage company Biotron (ASX: BIT) has announced it will commence the evaluation o...
Read ArticleOne of the best performers on the ASX on Thursday has been the Biotron Limited (ASX: BIT) share pri...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleAussie shares rose for a second day after Chinese stimulus measures helped a global market rebound g...
Read ArticleBy Tim Boreham, Editor, The New Criterion Stocks that tap the disaster zeitgeist With the stock mark...
Read ArticleA rebound on Wall Street and the possibility of a surprise rate cut this afternoon helped the share...
Read ArticleThe Australian share market tumbled 80 points as oil touched its lowest level in a year and Chinese...
Read ArticleCoronavirus scares and bushfire reconstruction play into the stock prices of small caps Biotron and...
Read ArticleRising coronavirus fears have ignited demand for Hollister Colltech’s (HTC) NatShield Sanitiser in...
Read ArticleAs global markets move cautiously around the spreading Wuhan coronavirus, the ASX managed to recoup...
Read ArticleBiotech researcher Biotron (BIT) has been in the spotlight this week for a potential coronavirus cu...
Read ArticleStocks retreated from record highs as strong jobs growth undermined the case for further rate cuts....
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleBoard member Robert Thomas purchased one million shares in the company yesterday and shares finished...
Read ArticleCancer is a crowded market, pot has sleep and pain issues covered — or so they say — and companies d...
Read ArticleDrug development is an extensive process and includes drug discovery & development, pre-clinical...
Read ArticleBiotron Limited (ASX: BIT) would be presenting its latest clinical trial data at the Conference on R...
Read ArticleBiotron (ASX BIT) has announced it has entered an Option Underwriting Agreement with Gleneag...
Read ArticleDrug Development Process The drug development process starts from drug discovery and ends at the lau...
Read ArticleThere are no shortage of small cap health and biotech companies listed on the ASX — around 140 or so...
Read ArticleIn Australia, there are plenty of high-quality health care companies, most of which have delivered e...
Read ArticleAustralian Health Care is a dynamic sector with a potential to generate significant profits in the l...
Read ArticleThe Australian benchmark index S&P/ASX200 was trading at 6,499.1, up by 0.09 per cent (as on 4 O...
Read ArticleOn 1 October 2005, I was only 20 metres away from a large bomb that went off in the heart of Kuta. T...
Read ArticleResources companies have come out on top in ASX small caps over the past 12 months – but now only ac...
Read ArticleAustralia has a robust health care system, jointly operated by the federal, state and local governme...
Read ArticleHolding huge growth potential, small cap stocks are those companies that are often under-recognised...
Read ArticleThe micro or small-cap end of the share market is full of shares that will regularly move rapidly h...
Read ArticleIn this piece of writing, we would discuss the three stocks from healthcare sector traded on the ASX...
Read ArticleThe stocks that trade for less than $1 per share and have very low market capitalisation are usually...
Read ArticleBiotron (ASX:BIT), the biotech company that skyrocketed 750 per cent in the space of a week after pr...
Read ArticleAustralian company Biotron (ASX:BIT) has updated shareholders following the release of posit...
Read Article
Open an account with an online broker of your choice. If you do not have an existing broker, consider Vested Equities' A$9.50 flat fee platform.
Sign up now »Place your order however you wish. If you need advice on buying or selling, you should seek the assistance of a full service financial adviser experienced in small cap equities.
